Literature DB >> 8743500

Protein glycation in the kidney: role in diabetes and aging.

H Vlassara1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8743500     DOI： 10.1038/ki.1996.270

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  21 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

Review 2.  [Non-enzymatic glycation and oxidative stress in chronic illnesses and diabetes mellitus].

Authors:  P P Nawroth; A Bierhaus; G E Vogel; M A Hofmann; M Zumbach; P Wahl; R Ziegler
Journal:  Med Klin (Munich)       Date:  1999-01-15

3.  Identification of the advanced glycation end products N(epsilon)-carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis.

Authors:  S Drinda; S Franke; C C Canet; P Petrow; R Bräuer; C Hüttich; G Stein; G Hein
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

4.  Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor.

Authors:  Weijing Cai; John C He; Li Zhu; Changyong Lu; Helen Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-05       Impact factor: 11.205

Review 5.  Mechanistic targeting of advanced glycation end-products in age-related diseases.

Authors:  Sheldon Rowan; Eloy Bejarano; Allen Taylor
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-08-29       Impact factor: 5.187

6.  Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons.

Authors:  Helen Vlassara; Jaime Uribarri; Luigi Ferrucci; Weijing Cai; Massimo Torreggiani; James B Post; Feng Zheng; Gary E Striker
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

7.  Peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria.

Authors:  Mahmut Ilker Yilmaz; Alper Sonmez; Kayser Caglar; Deniz Engin Gok; Tayfun Eyileten; Müjdat Yenicesu; Cengizhan Acikel; Necati Bingol; Selim Kilic; Yusuf Oguz; Abdulgaffar Vural
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

8.  High-glucose and advanced glycosylation end products increased podocyte permeability via PI3-K/Akt signaling.

Authors:  Tae-Sun Ha
Journal:  J Mol Med (Berl)       Date:  2010-01-08       Impact factor: 4.599

9.  Correlation between advanced glycation end-products and the expression of fatty inflammatory factors in type II diabetic cardiomyopathy.

Authors:  Zhengdong Guo; Donghui Huang; Xiange Tang; Jingjing Han; Jing Li
Journal:  Bosn J Basic Med Sci       Date:  2015-10-25       Impact factor: 3.363

10.  Effects of advanced glycosylation endproducts on perlecan core protein of glomerular epithelium.

Authors:  Tae-Sun Ha; Chang-Ju Song; Joon-Ho Lee
Journal:  Pediatr Nephrol       Date:  2004-09-22       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.